MAI Capital Management - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 58 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
MAI Capital Management ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$413,577
-4.6%
397,670
+29.3%
0.01%0.0%
Q2 2023$433,674
-28.1%
307,570
-18.9%
0.01%
-40.0%
Q1 2023$603,354
-3.2%
379,468
-11.1%
0.01%0.0%
Q4 2022$623,297
-77.1%
426,916
-33.0%
0.01%
-80.4%
Q3 2022$2,723,000
+8.3%
637,641
-1.6%
0.05%
+6.2%
Q2 2022$2,514,000
+38.7%
647,950
+70.2%
0.05%
+54.8%
Q1 2022$1,813,000380,7880.03%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$1,232,0000.82%
Samsara BioCapital, LLC 689,709$2,945,0000.69%
BVF INC/IL 3,614,662$15,435,0000.64%
Rubric Capital Management LP 994,801$4,248,0000.21%
HAMILTON LANE ADVISORS LLC 35,791$153,0000.06%
MAI Capital Management 637,641$2,723,0000.05%
Jasper Ridge Partners, L.P. 92,939$397,0000.03%
BOURGEON CAPITAL MANAGEMENT LLC 20,500$88,0000.02%
Ergoteles LLC 132,636$566,0000.02%
Laurion Capital Management LP 698,000$2,980,0000.02%
View complete list of VIRACTA THERAPEUTICS INC shareholders